Literature DB >> 2269468

Human rheumatoid synovial cell stimulation by the membrane attack complex and other pore-forming toxins in vitro: the role of calcium in cell activation.

R H Daniels1, B D Williams, B P Morgan.   

Abstract

The effects of non-lethal amounts of a variety of pore-forming agents on cultured human rheumatoid synovial cells (HRSC) have been investigated. Non-lethal complement membrane attack and non-lethal amounts of melittin, perforin and ionomycin all caused a biphasic release of prostaglandin E2 (PGE2) from HRSC, an early phase of release occurring within 1 hr and a second larger phase commencing after 4 hr and continuing over the 24-hr time-course. Removal of extracellular calcium abolished the release of PGE2 under all conditions of non-lethal attack. Modulation of G-protein activity reduced the second phase of release caused by non-lethal doses of the membrane-attack complex (MAC) from 800 ng/10(6) cells PGE2 to around 300 ng/10(6) cells. Non-lethal levels of the MAC also caused release of interleukin-6 (IL-6) from HRSC over the 24-hr time-course, with levels reaching 550 ng/10(6) cells at 24 hr compared to background levels of 200 ng/10(6) cells. No detectable release of IL-1 alpha could be measured at any time following non-lethal complement membrane attack. These results suggest a role for the MAC as an initiating mediator inducing the inflammation associated with rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2269468      PMCID: PMC1384424     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  Mechanism of cytolysis by complement.

Authors:  M M Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

2.  Immunoaffinity purification of human complement component C9 using monoclonal antibodies.

Authors:  B P Morgan; R A Daw; K Siddle; J P Luzio; A K Campbell
Journal:  J Immunol Methods       Date:  1983-11-25       Impact factor: 2.303

Review 3.  The role of protein kinase C in cell surface signal transduction and tumour promotion.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1984 Apr 19-25       Impact factor: 49.962

4.  Size of the transmembrane channels produced by complement proteins C5b-8.

Authors:  L E Ramm; M B Whitlow; M M Mayer
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

5.  The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum.

Authors:  E R Podack; W P Kolb; H J Müller-Eberhard
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

6.  Stimulation of human rheumatoid synovial cells by non-lethal complement membrane attack.

Authors:  R H Daniels; W A Houston; M M Petersen; J D Williams; B D Williams; B P Morgan
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

7.  Stimulation by human interleukin 1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoblasts in vitro.

Authors:  M Gowen; D D Wood; E J Ihrie; J E Meats; R G Russell
Journal:  Biochim Biophys Acta       Date:  1984-02-14

8.  Measurement of intracellular calcium ions and oxygen radicals in polymorphonuclear leucocyte-erythrocyte 'ghost' hybrids.

Authors:  A K Campbell; M B Hallett
Journal:  J Physiol       Date:  1983-05       Impact factor: 5.182

9.  Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides.

Authors:  M J Berridge; R M Dawson; C P Downes; J P Heslop; R F Irvine
Journal:  Biochem J       Date:  1983-05-15       Impact factor: 3.857

10.  Characterization of human complement components C6 and C7.

Authors:  R G Discipio; J Gagnon
Journal:  Mol Immunol       Date:  1982-11       Impact factor: 4.407

View more
  2 in total

1.  Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59.

Authors:  M Mizuno; K Nishikawa; B P Morgan; S Matsuo
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  Targeting of functional antibody-CD59 fusion proteins to a cell surface.

Authors:  H F Zhang; J Yu; E Bajwa; S L Morrison; S Tomlinson
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.